A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Clinical trial NCT05830240 · UNKNOWN
Trial details
- NCT number
- NCT05830240
- Sponsor
- Shanghai Yunying Medical Technology
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2025-03-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.